182 related articles for article (PubMed ID: 11027811)
1. An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs.
Dewulf J; Laevens H; Koenen F; Vanderhallen H; Mintiens K; Deluyker H; de Kruif A
Vaccine; 2000 Oct; 19(4-5):475-82. PubMed ID: 11027811
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
3. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
4. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
[TBL] [Abstract][Full Text] [Related]
5. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus.
Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
Vaccine; 2001 Oct; 20(1-2):86-91. PubMed ID: 11567750
[TBL] [Abstract][Full Text] [Related]
6. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
[TBL] [Abstract][Full Text] [Related]
7. Development of a classical swine fever subunit marker vaccine and companion diagnostic test.
Moormann RJ; Bouma A; Kramps JA; Terpstra C; De Smit HJ
Vet Microbiol; 2000 Apr; 73(2-3):209-19. PubMed ID: 10785329
[TBL] [Abstract][Full Text] [Related]
8. Vaccinology of classical swine fever: from lab to field.
van Oirschot JT
Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
[TBL] [Abstract][Full Text] [Related]
10. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples.
Dewulf J; Koenen F; Ribbens S; Haegeman A; Laevens H; De Kruif A
J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):367-71. PubMed ID: 16283914
[TBL] [Abstract][Full Text] [Related]
12. Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.
Laughlin RC; Madera R; Peres Y; Berquist BR; Wang L; Buist S; Burakova Y; Palle S; Chung CJ; Rasmussen MV; Martel E; Brake DA; Neilan JG; Lawhon SD; Adams LG; Shi J; Marcel S
Plant Biotechnol J; 2019 Feb; 17(2):410-420. PubMed ID: 29993179
[TBL] [Abstract][Full Text] [Related]
13. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus.
Bouma A; De Smit AJ; De Jong MC; De Kluijver EP; Moormann RJ
Vaccine; 2000 Jan; 18(14):1374-81. PubMed ID: 10618535
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
15. Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.
Depner KR; Bouma A; Koenen F; Klinkenberg D; Lange E; de Smit H; Vanderhallen H
Vet Microbiol; 2001 Nov; 83(2):107-20. PubMed ID: 11557152
[TBL] [Abstract][Full Text] [Related]
16. Influence of maternal antibodies on efficacy of a subunit vaccine: transmission of classical swine fever virus between pigs vaccinated at 2 weeks of age.
Klinkenberg D; Moormann RJ; de Smit AJ; Bouma A; de Jong MC
Vaccine; 2002 Jul; 20(23-24):3005-13. PubMed ID: 12126914
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
Bouma A; de Smit AJ; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 1999 Apr; 66(2):101-14. PubMed ID: 10227472
[TBL] [Abstract][Full Text] [Related]
18. The effect of vaccination with the PAV-250 strain classical swine fever (CSF) virus on the airborne transmission of CSF virus.
Gonzalez C; Pijoan C; Ciprian A; Correa P; Mendoza S
J Vet Med Sci; 2001 Sep; 63(9):991-6. PubMed ID: 11642288
[TBL] [Abstract][Full Text] [Related]
19. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection of slaughter pigs with classical swine fever virus: transmission of the virus, course of the disease and antibody response.
Laevens H; Koenen F; Deluyker H; de Kruif A
Vet Rec; 1999 Aug; 145(9):243-8. PubMed ID: 10504066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
